Reply:

References

1. 1.↵
   1. Wang L

   . Letter: Emergency department visits for chronic subdural hematomas within 30 days after surgical evacuation with and without middle meningeal artery embolization. J Neurointerv Surg 2022. In press
2. 2.↵
   1. Catapano JS,
   2. Scherschinski L,
   3. Rumalla K, et al

   . Emergency department visits for chronic subdural hematomas within 30 days after surgical evacuation with and without middle meningeal artery embolization. AJNR Am J Neuroradiol 2022;43:1148–51 doi:10.3174/ajnr.A7572 pmid:35863784

   Abstract/FREE Full Text
3. 3.↵
   1. Kan P,
   2. Maragkos GA,
   3. Srivatsan A, et al

   . Middle meningeal artery embolization for chronic subdural hematoma: a multi-center experience of 154 consecutive embolizations. Neurosurgery 2021;88:268–77 doi:10.1093/neuros/nyaa379 pmid:33026434

   CrossRefPubMed
4. 4.↵
   1. Ng S,
   2. Derraz I,
   3. Boetto J, et al

   . Middle meningeal artery embolization as an adjuvant treatment to surgery for symptomatic chronic subdural hematoma: a pilot study assessing hematoma volume resorption. J Neurointerv Surg 2020;12:695–99 doi:10.1136/neurintsurg-2019-015421 pmid:31862830

   Abstract/FREE Full Text
5. 5.↵
   1. Catapano JS,
   2. Ducruet AF,
   3. Nguyen CL, et al

   . A propensity-adjusted comparison of middle meningeal artery embolization versus conventional therapy for chronic subdural hematomas. J Neurosurg 2021 Feb 26. [Epub ahead of print] doi:10.3171/2020.9.JNS202781 pmid:33636706

   CrossRefPubMed
6. 6.↵
   1. Catapano JS,
   2. Koester SW,
   3. Srinivasan VM, et al

   . Total 1-year hospital cost of middle meningeal artery embolization compared to surgery for chronic subdural hematomas: a propensity-adjusted analysis. J Neurointerv Surg 2022;14:804–06 doi:10.1136/neurintsurg-2021-018327 pmid:34880075

   Abstract/FREE Full Text
7. 7.↵
   1. Chang CL,
   2. Sim JL,
   3. Delgardo MW, et al

   . Predicting chronic subdural hematoma resolution and time to resolution following surgical evacuation. Front Neurol 2020;11:677 doi:10.3389/fneur.2020.00677 pmid:32760342

   CrossRefPubMed
8. 8.↵
   1. Guha D,
   2. Coyne S,
   3. Macdonald RL

   . Timing of the resumption of antithrombotic agents following surgical evacuation of chronic subdural hematomas: a retrospective cohort study. J Neurosurg 2016;124:750–59 doi:10.3171/2015.2.JNS141889 pmid:26361283

   CrossRefPubMed
9. 9.↵
   1. Poon MT,
   2. Rea C,
   3. Kolias AG

   ; et al; British Neurosurgical Trainee Research Collaborative (BNTRC). Influence of antiplatelet and anticoagulant drug use on outcomes after chronic subdural hematoma drainage. J Neurotrauma 2021;38:1177–84 doi:10.1089/neu.2018.6080 pmid:30526281

   CrossRefPubMed
10. 10.↵
    1. Scerrati A,
    2. Germano A,
    3. Trevisi G, et al

    . Timing of low-dose aspirin discontinuation and the influence on clinical outcome of patients undergoing surgery for chronic subdural hematoma. World Neurosurg 2019;129:e695–99 doi:10.1016/j.wneu.2019.05.252 pmid:31279757

    CrossRefPubMed
11. 11.↵
    1. Housley SB,
    2. Monteiro A,
    3. Donnelly BM, et al

    . Statins versus nonstatin use in patients with chronic subdural hematomas treated with middle meningeal artery embolization alone: a single-center experience. World Neurosurg 2022 Oct 15. [Epub ahead of print] doi:10.1016/j.wneu.2022.10.027 pmid:36243361

    CrossRefPubMed